Myeloblastin

Handbook of Proteolytic Enzymes

Volumn 3, Issue , 2013, Pages 2666-2675

  Rao, Narayanam V ^a   Hoidal, John R ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884872954     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382219-2.00589-5     Document Type: Chapter

References (105)

1. Bories D., Raynal M.C., Solomon D.H., Darzynkiewicz Z., Cayre Y.E. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 1989, 59(6):959-968.
2. Baggiolini M., Bretz U., Dewald B., Feigenson M.E. The polymorphonuclear leukocyte. Agents Actions 1978, 8(1-2):3-10.
3. Kao R.C., Wehner N.G., Skubitz K.M., Gray B.H., Hoidal J.R. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest. 1988, 82(6):1963-1973.
4. Campanelli D., Melchior M., Fu Y., Nakata M., Shuman H., Nathan C., Gabay J.E. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J. Exp. Med. 1990, 172(6):1709-1715.
5. Rao N.V., Wehner N.G., Marshall B.C., Gray W.R., Gray B.H., Hoidal J.R. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J. Biol. Chem. 1991, 266(15):9540-9548.
6. Fruh H., Kostoulas G., Michel B.A., Baici A. Human myeloblastin (leukocyte proteinase 3): reactions with substrates, inactivators and activators in comparison with leukocyte elastase. Biol. Chem. 1996, 377(9):579-586.
7. Koehl C., Knight C.G., Bieth J.G. Compared action of neutrophil proteinase 3 and elastase on model substrates. Favorable effect of S'-P' interactions on proteinase 3 catalysts. J. Biol. Chem. 2003, 278(15):12609-12612.
8. Brubaker M.J., Groutas W.C., Hoidal J.R., Rao N.V. Human neutrophil proteinase 3: mapping of the substrate binding site using peptidyl thiobenzyl esters. Biochem. Biophys. Res. Commun. 1992, 188(3):1318-1324.
9. Kam C.M., Kerrigan J.E., Dolman K.M., Goldschmeding R., Von dem Borne A.E., Powers J.C. Substrate and inhibitor studies on proteinase 3. FEBS Lett. 1992, 297(1-2):119-123.
10. Ying Q.L., Simon S.R. Kinetics of the inhibition of proteinase 3 by elafin. Am. J. Respir. Cell Mol. Biol. 2001, 24(1):83-89.
11. Korkmaz B., Attucci S., Hazouard E., Ferrandiere M., Jourdan M.L., Brillard-Bourdet M., Juliano L., Gauthier F. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. J. Biol. Chem. 2002, 277(42):39074-39081.
12. Wysocka M., Lesner A., Guzow K., Mackiewicz L., Legowska A., Wiczk W., Rolka K. Design of selective substrates of proteinase 3 using combinatorial chemistry methods. Anal. Biochem. 2008, 378(2):208-215.
13. Wysocka M., Lesner A., Majkowska G., Legowska A., Guzow K., Rolka K., Wiczk W. The new fluorogenic substrates of neutrophil proteinase 3 optimized in prime site region. Anal. Biochem. 2010, 399(2):196-201.
14. Wysocka M., Lesner A., Guzow K., Kulczycka J., Legowska A., Wiczk W., Rolka K. Highly specific substrates of proteinase 3 containing 3-(2-benzoxazol-5-yl)-l-alanine and their application for detection of this enzyme in human serum. Anal. Chem. 2010, 82(9):3883-9889.
15. Cooley J., Takayama T.K., Shapiro S.D., Schechter N.M., Remold-O'Donnell E. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 2001, 40(51):15762-15770.
16. Wiedow O., Ludemann J., Utecht B., Christophers E. Inhibition of proteinase 3 activity by peptides derived from human epidermis. Adv. Exp. Med. Biol. 1993, 336:61-64.
17. Zani M.L., Nobar S.M., Lacour S.A., Lemoine S., Boudier C., Bieth J.G., Moreau T. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris. Eur. J. Biochem. 2004, 271(12):2370-2378.
18. Doucet A., Bouchard D., Janelle M.F., Bellemare A., Gagne S., Tremblay G.M., Bourbonnais Y. Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema. Biochem. J. 2007, 405(3):455-463.
19. Korkmaz B., Jaillet J., Jourdan M.L., Gauthier A., Gauthier F., Attucci S. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J. Biol. Chem. 2009, 284(30):19896-19902.
20. Zani M.L., Baranger K., Guyot N., Dallet-Choisy S., Moreau T. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases. Protein Sci. 2009, 18(3):579-594.
21. Groutas W.C., Ruan S., Kuang R., Hook J.B., Sands H. Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032). Biochem. Biophys. Res. Commun. 1997, 233(3):697-699.
22. Groutas W.C., He S., Kuang R., Ruan S., Tu J., Chan H.K. Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. Bioorg. Med. Chem. 2001, 9(6):1543-1548.
23. Groutas W.C., Kuang R., Ruan S., Epp J.B., Venkataraman R., Truong T.M. Potent and specific inhibition of human leukocyte elastase, cathepsin G and proteinase 3 by sulfone derivatives employing the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. Bioorg. Med. Chem. 1998, 6(6):661-671.
24. Wieczorek M., Gyorkos A., Spruce L.W., Ettinger A., Ross S.E., Kroona H.S., Burgos-Lepley C.E., Bratton L.D., Drennan T.S., Garnert D.L., Von Burg G., Pilkington C.G., Cheronis J.C. Biochemical characterization of alpha-ketooxadiazole inhibitors of elastases. Arch. Biochem. Biophys. 1999, 367(2):193-201.
25. Cadene M., Duranton J., North A., Si-Tahar M., Chignard M., Bieth J.G. Inhibition of neutrophil serine proteinases by suramin. J. Biol. Chem. 1997, 272(15):9950-9955.
26. Fujinaga M., Chernaia M.M., Halenbeck R., Koths K., James M.N. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J. Mol. Biol. 1996, 261(2):267-278.
27. Rasmussen N., Sjolin C., Isaksson B., Bygren P., Wieslander J. An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA). J. Immunol. Methods 1990, 127(1):139-145.
28. Bini P., Gabay J.E., Teitel A., Melchior M., Zhou J.L., Elkon K.B. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J. Immunol. 1992, 149(4):1409-1415.
29. Harmsen M.C., Heeringa P., van der Geld Y.M., Huitema M.G., Klimp A., Tiran A., Kallenberg C.G. Recombinant proteinase 3 (Wegener's antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera. Clin. Exp. Immunol. 1997, 110(2):257-264.
30. Witko-Sarsat V., Halbwachs-Mecarelli L., Almeida R.P., Nusbaum P., Melchior M., Jamaleddine G., Lesavre P., Descamps-Latscha B., Gabay J.E. Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies. FEBS Lett. 1996, 382(1-2):130-136.
31. Szymkowiak C.H., Johnston T.W., Csernok E., Gross W.L. Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression system. Biochem. Biophys. Res. Commun. 1996, 219(2):283-289.
32. Rarok A.A., Huitema M.G., van der Leij M.J., van der Geld Y.M., Berthold H., Schmitt J., Stegeman C.A., Limburg P.C., Kallenberg C.G. Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis. Am. J. Clin. Pathol. 2003, 120(4):586-595.
33. Specks U., Fass D.N., Fautsch M.P., Hummel A.M., Viss M.A. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA. FEBS Lett. 1996, 390(3):265-270.
34. Sun J., Fass D.N., Viss M.A., Hummel A.M., Tang H., Homburger H.A., Specks U. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide. Clin. Exp. Immunol. 1998, 114(2):320-326.
35. Jenne D.E., Kuhl A. Production and applications of recombinant proteinase 3, Wegener's autoantigen: problems and perspectives. Clin. Nephrol. 2006, 66(3):153-159.
36. Sturrock A.B., Franklin K.F., Rao G., Marshall B.C., Rebentisch M.B., Lemons R.S., Hoidal J.R. Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen. J. Biol. Chem. 1992, 267(29):21193-21199.
37. Zimmer M., Medcalf R.L., Fink T.M., Mattmann C., Lichter P., Jenne D.E. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc. Natl. Acad. Sci. USA 1992, 89(17):8215-8219.
38. Sturrock A.B., Espinosa R., Hoidal J.R., Le Beau M.M. Localization of the gene encoding proteinase-3 (the Wegener's granulomatosis autoantigen) to human chromosome band 19p13.3. Cytogenet. Cell Genet. 1993, 64(1):33-34.
39. Belaaouaj A., Moog-Lutz C., Just J., Houzel-Charavel A., Shapiro S.D., Cayre Y. Genomic organization and chromosomal localization of mouse proteinase 3 (Myeloblastin). Mamm. Genome 1999, 10(3):210-212.
40. Sturrock A., Franklin K.F., Wu S., Hoidal J.R. Characterization and localization of the genes for mouse proteinase-3 (Prtn3) and neutrophil elastase (Ela2). Cytogenet. Cell Genet. 1998, 83(1-2):104-108.
41. Sturrock A., Franklin K.F., Hoidal J.R. Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element. J. Biol. Chem. 1996, 271(50):32392-32402.
42. Nuchprayoon I., Meyers S., Scott L.M., Suzow J., Hiebert S., Friedman A.D. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell Biol. 1994, 14(8):5558-5568.
43. Nuchprayoon I., Simkevich C.P., Luo M., Friedman A.D., Rosmarin A.G. GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter. Blood 1997, 89(12):4546-4554.
44. Oelgeschlager M., Nuchprayoon I., Luscher B., Friedman A.D. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell Biol. 1996, 16(9):4717-4725.
45. Clave E., Carosella E.D., Gluckman E., Socie G. Radiation-enhanced expression of interferon-inducible genes in the KG1a primitive hematopoietic cell line. Leukemia 1997, 11(1):114-119.
46. Gencik M., Meller S., Borgmann S., Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int. 2000, 58(6):2473-2477.
47. Aveskogh M., Lutzelschwab C., Huang M.R., Hellman L. Characterization of cDNA clones encoding mouse proteinase 3 (myeloblastine) and cathepsin G. Immunogenetics 1997, 46(3):181-191.
48. Davies B.J., Pickard B.S., Steel M., Morris R.G., Lathe R. Serine proteases in rodent hippocampus. J. Biol. Chem. 1998, 273(36):23004-23011.
49. Rao N.V., Rao G.V., Marshall B.C., Hoidal J.R. Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J. Biol. Chem. 1996, 271(6):2972-2978.
50. Gabay J.E., Almeida R.P. Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin. Curr. Opin. Immunol. 1993, 5(1):97-102.
51. Kobayashi S.D., Voyich J.M., Burlak C., DeLeo F.R. Neutrophils in the innate immune response. Arch. Immunol. Ther. Exp. (Warsz) 2005, 53(6):505-517.
52. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303(5663):1532-1535.
53. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., Grone H.J., Brinkmann V., Jenne D.E. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009, 15(6):623-625.
54. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001, 97(12):3951-3959.
55. Durr U.H., Sudheendra U.S., Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 2006, 1758(9):1408-1425.
56. Campanelli D., Detmers P.A., Nathan C.F., Gabay J.E. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 1990, 85(3):904-915.
57. Mackarel A.J., Cottell D.C., Russell K.J., FitzGerald M.X., O'Connor C.M. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am. J. Respir. Cell Mol. Biol. 1999, 20(6):1209-1219.
58. Bank U., Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 2001, 69(2):197-206.
59. Pham C.T. Neutrophil serine proteases fine-tune the inflammatory response. Int. J. Biochem. Cell Biol. 2008, 40(6-7):1317-1333.
60. Meyer-Hoffert U. Neutrophil-derived serine proteases modulate innate immune responses. Front Biosci. 2009, 14:3409-3418.
61. Padrines M., Wolf M., Walz A., Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 1994, 352(2):231-235.
62. Berger S.P., Seelen M.A., Hiemstra P.S., Gerritsma J.S., Heemskerk E., van der Woude F.J., Daha M.R. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J. Am. Soc. Nephrol. 1996, 7(5):694-701.
63. Robache-Gallea S., Morand V., Bruneau J.M., Schoot B., Tagat E., Realo E., Chouaib S., Roman-Roman S. In vitro processing of human tumor necrosis factor-alpha. J. Biol. Chem. 1995, 270(40):23688-23692.
64. Coeshott C., Ohnemus C., Pilyavskaya A., Ross S., Wieczorek M., Kroona H., Leimer A.H., Cheronis J. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. USA 1999, 96(11):6261-6266.
65. Sugawara S., Uehara A., Nochi T., Yamaguchi T., Ueda H., Sugiyama A., Hanzawa K., Kumagai K., Okamura H., Takada H. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 2001, 167(11):6568-6575.
66. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C.A., Kim S.H. Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. USA 2006, 103(9):3316-3321.
67. Kim S., Lee S., Her E., Bae S., Choi J., Hong J., Jaekal J., Yoon D., Azam T., Dinarello C.A. Proteinase 3-processed form of the recombinant IL-32 separate domain. BMB Rep. 2008, 41(11):814-819.
68. Csernok E., Szymkowiak C.H., Mistry N., Daha M.R., Gross W.L., Kekow J. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin. Exp. Immunol. 1996, 105(1):104-111.
69. Zhu J., Nathan C., Jin W., Sim D., Ashcroft G.S., Wahl S.M., Lacomis L., Erdjument-Bromage H., Tempst P., Wright C.D., Ding A. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002, 111(6):867-878.
70. Kessenbrock K., Frohlich L., Sixt M., Lammermann T., Pfister H., Bateman A., Belaaouaj A., Ring J., Ollert M., Fassler R., Jenne D.E. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J. Clin. Invest. 2008, 118(7):2438-2447.
71. Vong L., D'Acquisto F., Pederzoli-Ribeil M., Lavagno L., Flower R.J., Witko-Sarsat V., Perretti M. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J. Biol. Chem. 2007, 282(41):29998-30004.
72. Pederzoli-Ribeil M., Maione F., Cooper D., Al-Kashi A., Dalli J., Perretti M., D'Acquisto F. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 2010, 116(20):4288-4296.
73. Ramaha A., Patston P.A. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases. Arch. Biochem. Biophys. 2002, 397(1):77-83.
74. Uehara A., Sugawara S., Muramoto K., Takada H. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J. Immunol. 2002, 169(8):4594-4603.
75. Witko-Sarsat V., Canteloup S., Durant S., Desdouets C., Chabernaud R., Lemarchand P., Descamps-Latscha B. Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J. Biol. Chem. 2002, 277(49):47338-47347.
76. Dublet B., Ruello A., Pederzoli M., Hajjar E., Courbebaisse M., Canteloup S., Reuter N., Witko-Sarsat V. Cleavage of p21/WAF1/CIP1 by proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site. J. Biol. Chem. 2005, 280(34):30242-30253.
77. Preston G.A., Zarella C.S., Pendergraft W.F., Rudolph E.H., Yang J.J., Sekura S.B., Jennette J.C., Falk R.J. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. J. Am. Soc. Nephrol. 2002, 13(12):2840-2849.
78. Pendergraft W.F., Rudolph E.H., Falk R.J., Jahn J.E., Grimmler M., Hengst L., Jennette J.C., Preston G.A. Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney Int. 2004, 65(1):75-84.
79. Pederzoli M., Kantari C., Gausson V., Moriceau S., Witko-Sarsat V. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. J. Immunol. 2005, 174(10):6381-6390.
80. Spector N.L., Hardy L., Ryan C., Miller W.H., Humes J.L., Nadler L.M., Luedke E. 28-kDa mammalian heat shock protein, a novel substrate of a growth regulatory protease involved in differentiation of human leukemia cells. J. Biol. Chem. 1995, 270(3):1003-1006.
81. Leid R.W., Ballieux B.E., van der Heijden I., Kleyburg-van der Keur C., Hagen E.C., van Es L.A., van der Woude F.J., Daha M.R. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3. Eur. J. Immunol. 1993, 23(11):2939-2944.
82. Rao J., Zhang F., Donnelly R.J., Spector N.L., Studzinski G.P. Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL60 cells. J. Cell Physiol. 1998, 175(2):121-128.
83. Raife T.J., Cao W., Atkinson B.S., Bedell B., Montgomery R.R., Lentz S.R., Johnson G.F., Zheng X.L. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood 2009, 114(8):1666-1674.
84. Alexander R.W., Schimmel P. Evidence for breaking domain-domain functional communication in a synthetase-tRNA complex. Biochemistry 1999, 38(49):16359-16365.
85. Ludemann J., Utecht B., Gross W.L. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J. Exp. Med. 1990, 171(1):357-362.
86. Gross W.L., Csernok E., Helmchen U. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. APMIS 1995, 103(2):81-97.
87. Porges A.J., Redecha P.B., Kimberly W.T., Csernok E., Gross W.L., Kimberly R.P. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J. Immunol. 1994, 153(3):1271-1280.
88. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. USA 1990, 87(11):4115-4119.
89. Savage C.O., Pottinger B.E., Gaskin G., Pusey C.D., Pearson J.D. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am. J. Pathol. 1992, 141(2):335-342.
90. Brouwer E., Stegeman C.A., Huitema M.G., Limburg P.C., Kallenberg C.G. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin. Exp. Immunol. 1994, 98(3):448-453.
91. Kuhl A., Korkmaz B., Utecht B., Kniepert A., Schonermarck U., Specks U., Jenne D.E. Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis. J. Immunol. 2010, 185(1):387-399.
92. Rao N.V., Marshall B.C., Gray B.H., Hoidal J.R. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am. J. Respir. Cell Mol. Biol. 1993, 8(6):612-616.
93. Duranton J., Belorgey D., Carrere J., Donato L., Moritz T., Bieth J.G. Effect of DNase on the activity of neutrophil elastase, cathepsin G and proteinase 3 in the presence of DNA. FEBS Lett. 2000, 473(2):154-156.
94. Guillabert A., Wittamer V., Bondue B., Godot V., Imbault V., Parmentier M., Communi D. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J. Leukoc. Biol. 2008, 84(6):1530-1538.
95. Calafat J., Goldschmeding R., Ringeling P.L., Janssen H., van der Schoot C.E. In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes. Blood 1990, 75(1):242-250.
96. Almeida R.P., Melchior M., Campanelli D., Nathan C., Gabay J.E. Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteases. Biochem. Biophys. Res. Commun. 1991, 177(2):688-695.
97. Jenne D.E., Zimmer M., Garcia-Sanz J.A., Tschopp J., Lichter P. Genomic organization and subchromosomal in situ localization of the murine granzyme F, a serine protease expressed in CD8+ T cells. J. Immunol. 1991, 147(3):1045-1052.
98. Korkmaz B., Horwitz M.S., Jenne D.E., Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol. Rev. 2010, 62(4):726-759.
99. Hajjar E., Broemstrup T., Kantari C., Witko-Sarsat V., Reuter N. Structures of human proteinase 3 and neutrophil elastase - so similar yet so different. FEBS J. 2010, 277(10):2238-2254.
100. Kessenbrock K., Dau T., Jenne D.E. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J. Mol. Med. 2011, 89(1):23-28.
101. Nakajima K., Powers J.C., Ashe B.M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J. Biol. Chem. 1979, 254(10):4027-4032.
102. Yasutake A., Powers J.C. Reactivity of human leukocyte elastase and porcine pancreatic elastase toward peptide 4-nitroanilides containing model desmosine residues. Evidence that human leukocyte elastase is selective for cross-linked regions of elastin. Biochemistry 1981, 20(13):3675-3967.
103. Stein R.L., Strimpler A.M., Hori H., Powers J.C. Catalysis by human leukocyte elastase: mechanistic insights into specificity requirements. Biochemistry 1987, 26(5):1301-1305.
104. Harper J.W., Cook R.R., Roberts C.J., McLaughlin B.J., Powers J.C. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates. Biochemistry 1984, 23(13):2995-3002.
105. Korkmaz B., Attucci S., Moreau T., Godat E., Juliano L., Gauthier F. Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am. J. Respir. Cell Mol. Biol. 2004, 30(6):801-807.